High bone density is associated with prostate cancer in older Afro-Caribbean men: Tobago Prostate Survey

Cancer Causes and Control

Volumn 17, Issue 8, 2006, Pages 1083-1089

  Bunker, Clareann H ^a   Zmuda, Joseph M ^a   Patrick, Alan L ^a,b   Wheeler, Victor W ^b   Weissfeld, Joel L ^a   Kuller, Lewis H ^a   Cauley, Jane A ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b Tobago Health Studies Office   (Trinidad and Tobago)

Author keywords

Afro Caribbean; Bone mineral density; Hormones; Prostate cancer

Indexed keywords

CALCIUM; GROWTH FACTOR; HORMONE; PROSTATE SPECIFIC ANTIGEN; VITAMIN D;

ADULT; AFRICAN CARIBBEAN; AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; BONE DENSITY; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; GROUPS BY AGE; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SEX ROLE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; AGING; BONE DENSITY; CASE-CONTROL STUDIES; HEALTH SURVEYS; HIP; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PROSTATIC NEOPLASMS; TRINIDAD AND TOBAGO;

EID: 33747878358     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-006-0047-1     Document Type: Article

References (42)

1. Ries LAG, Eisner MP, Kosary CL, et al (eds) (2005) SEER Cancer Statistics Review, 1975-2002, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2002/, based on November 2004 SEER data submission, posted to the SEER web site 2005, Table XXII-2
2. Glover Jr FE, Coffey DS, Douglas LL, et al (1998) The epidemiology of prostate cancer in Jamaica. J Urol 159:1984-1987
3. CH Bunker AL Patrick BR Konety 2002 High prevalence of Screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Survey Cancer Epidemiol Biomark Prev 11 726 729
4. R Ross L Bernstein H Judd R Hanisch M Pike B Henderson 1986 Serum testosterone levels in healthy young black and white men J Natl Cancer Inst 76 45 48
5. AH Wu AS Whittemore LN Kolonel 1995 Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada Cancer Epidemiol Biomark Prev 4 735 741
6. EA Platz EB Rimm WC Willett PW Kantoff E Giovannucci 2000 Racial variation in prostate cancer incidence in hormonal system markers among male health professionals J Natl Cancer Inst 92 2009 2017
7. VR Panz BI Joffe I Spitz T Lindenberg A Farkas M Haffejee 2001 Tandem CAG repeats of the androgen receptor gene and prostate cancer risk in black and white men Endocrine 15 213 216
8. O Sartor Q Zheng JA Eastham 1999 Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer Urology 53 378 380
9. RA Kittles D Young S Weinrich 2001 Extent of linkage disequilibrium between the androgen receptor gene CAG and GCC repeats in human populations: implications for prostate cancer risk Hum Genet 109 253 261
10. CL Bennett DK Price S Kim 2002 Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status J Clin Oncol 20 3599 3604
11. NL Chamberlain ED Driver RL Miesfeld 1994 The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function Nucl Acids Res 22 3181 3186
12. Q Wang TS Udayakumar TS Vasaitis AM Brodie JD Fondell 2004 Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells J Biol Chem 279 17319 17328
13. MA Albertelli A Scheller M Brogley DM Robins 2006 Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length dependent effects on physiology and tumorigenesis in mice Mol Endocrinol 20 1248 1260
14. JM Chan MJ Stampfer E Giovanucci 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study Science 279 563 566
15. P Stattin A Bylund S Rinaldi 2000 Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study J Nat Cancer Inst 92 1910 1917
16. A Wolk CS Mantzoros S-O Andersson 1998 Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study J Nat Cancer Inst 90 911 915
17. R Shi HJ Berkel H Yu 2001 Insulin-like growth factor-I and prostate cancer: a meta-analysis Br J Cancer 85 991 996
18. JK Cruickshank AH Heald S Anderson 2001 Epidemiology of the insulin-like growth factor system in three ethnic groups Am J Epidemiol 54 504 513
19. JA Cauley FL Lucas LH Kuller MT Vogt WS Browner SR Cummings 1996 Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group JAMA 276 1404 1408
20. Zmuda JM, Cauley JA, Ljung BM, Bauer DC, Cummings SR, Kuller LH. Study of Osteoporotic Fractures Research Group (2001) Bone mass and breast cancer risk in older women: differences by stage at diagnosis. J Nat Cancer Inst 93:930-936
21. CA Conover 2000 Insulin-like growth factors and the skeleton E Canalis Skeletal growth factors Lippincott Williams & Wilkins Philadelphia USA 101 116
22. KM Wiren ES Orwoll 1999 Androgens and bone: basic aspects ES Orwoll Osteoporosis in men: the effects of gender on skeletal health Academic Press San Diego, USA 211 245
23. CJ Rosen 2000 IGF-I and osteoporosis Clin Lab Med 20 591 602
24. AM Parfitt 1997 Genetic effects on bone mass and turnover-relevance to black/white differences J Am Coll Nutr 16 325 333
25. Y Zhang DP Kiel RC Ellison 2002 Bone mass and the risk of prostate cancer: The Framingham Study Am J Med 113 734 739
26. JP Richie WJ Catalona FR Ahmann 1993 Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination Urology 42 365 374
27. AC Looker HW Wahner WL Dunn 1998 Updated data on proximal femur bone mineral levels of US adults Osteopor Internat 8 468 489
28. J Cauley JM Zmuda A Patrick VW Wheeler D Hill C Bunker 2001 Tobago Bone Health Study: Epidemiologic Study of high bone mineral density on a population level J Bone Min Res 16 Suppl 1 M357
29. Nelson RL, Turyk M, Kim J, Persky V (2002) Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort. BMC Cancer 2:22 (accessed 12 March 2004 at http://www.biomedcentral.com/1471-2407/2/22)
30. RL Wolf JM Zmuda KL Stone JA Cauley 2000 Update on the epidemiology of osteoporosis Curr Rheumatol Rep 2 74 86
31. GA Greendale S Edelstein E Barrett-Connor 1997 Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo Study J Bone Miner Res 12 1833 1843
32. MC Bosland 2000 The role of steroid hormones in prostate carcinogenesis J Natl Cancer Inst Monogr 27 39 66
33. AW Hsing JKV Reichardt FZ Stanczyk 2002 Hormones and prostate cancer: current perspective and future directions Prostate 52 213 235
34. AW Hsing C Streamson Y-T Gao E Gentzchien L Chang FZ Stanczyk 2001 Serum levels of insulin and leptin in relation to prostate cancer risk: a population-based case-control study in China J Natl Cancer Inst 93 783 789
35. RP Stolk PL Van Daele HA Pols 1996 Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam Study.[erratum appears in Bone. 1996; 19: 566] Bone 18 545 549
36. DM Peehl TA Stamey 1986 Serum-free growth of adult human prostatic epithelial cells In Vitro Cell Dev Biol 22 82 90
37. JA Cauley JM Zmuda AB Newman 2003 Circulating levels of soluble cytokine receptors predict incident fractures in older men and women: The Health Aging and Body Composition Study (HABC) J Bone Miner Res 18 Suppl 2 S84
38. M Kawada M Ishizuka T Takeuchi 1999 Enhancement of antiproliferative effects of interleukin-1beta and tumor necrosis factor-alpha on human prostate cancer LNCaP cells by coculture with normal fibroblasts through secreted interleukin-6 Jpn J Cancer Res 90 546 554
39. Y Nakajima A DelliPizzi C Mallouh N Ferreri 1995 Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of human prostate cancer cell lines Urol Res 23 205 210
40. OW Rokhlin AV Gudkov S Kwek RA Glover AS Gewies MB Cohen 2000 p53 is involved in tumor necrosis factor-alpha-induced apoptosis in the human prostatic carcinoma cell line LNCaP Oncogene 19 1959 1968
41. ES Orwoll L Bevan KR Phipps 2000 Determinants of bone mineral density in older men Osteopor Internat 11 815 821
42. AM Nomura 2001 Body size and prostate cancer Epidemiol Rev 23 126 131